IP Library Granted Patent US 9,096,629
Granted Patent B2
US 9,096,629 · App. 13/981,551 · Granted Aug 4, 2015

Process of forming iron hydroxypyrone compounds

Inventor: Michael Arthur Stockham (Saffron Walden, GB)
Assignee: Iron Therapeutics Holdings AG
C07F15/025A61K31/351A61K33/26C07D309/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,096,629
App. No.
13/981,551
Granted
Aug 4, 2015
Kind
B2
Abstract

The invention provides a method of forming an iron hydroxypyrone compound comprising reacting a hydroxypyrone with a non-carboxylate iron salt in an aqueous solution, and precipitating the iron hydroxypyrone compound from the aqueous solution having a pH of greater than 7.

Claims (18)

1. A method of forming iron tri(maltol) comprising:

combining maltol with an aqueous solution having a pH of 3 to about 7;

heating the combined maltol and aqueous solution to form a heated maltol solution having a pH of 3 to 7;

combining the heated maltol solution with a non-carboxylate iron salt to form a solution having a pH of 3 to 7;

combining the solution having a pH of 3 to 7 with an aqueous alkaline solution comprising maltol, wherein the aqueous alkaline solution has a pH of greater than 7; and

precipitating iron tri(maltol) from the combined solutions having a pH of greater than 7.

2. The method of claim 1 , wherein the non-carboxylate iron salt is selected from a ferrous or a ferric salt and mixtures thereof.

3. The method according to claim 1 , wherein the aqueous solution comprises water in an amount of greater than 30% v/v of the total solution.

4. The method according to claim 1 , wherein the precipitate is separated and collected and, optionally, dried.

5. A method of forming iron tri(maltol) comprising:

forming an aqueous solution having a pH of less than 7 comprising iron monomaltol, iron di(maltol), or a mixture thereof by combining a non-carboxylate iron salt with a maltol solution having a pH of less than 7;

adding further maltol to the aqueous solution having a pH of less than 7;

increasing the pH of the aqueous solution to greater than 7; and

precipitating the iron tri(maltol) from the aqueous solution having a pH of greater than 7.

6. The method according to claim 5 wherein the further maltol is in an aqueous alkaline solution.

7. The method of claim 5 , wherein the non-carboxylate iron salt is selected from a ferrous or a ferric salt and mixtures thereof.

8. The method according to claim 5 , wherein the aqueous solution comprises water in an amount of greater than 30% v/v of the total solution.

9. The method according to claim 5 , wherein the precipitate is separated and collected and, optionally, dried.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 4, 2023
From: AOP HEALTH INTERNATIONAL MANAGEMENT AG
To: SHIELD TX (UK) LIMITED
Reel/Frame 065125/0610 →
SECURITY INTEREST Recorded Oct 4, 2023
From: SHIELD TX (UK) LIMITED
To: SWK FUNDING LLC
Reel/Frame 065126/0142 →
SECURITY INTEREST Recorded Jan 4, 2023
From: AOP HEALTH INTERNATIONAL MANAGEMENT
To: SHIELD TX (UK) LIMITED
Reel/Frame 062273/0488 →
SECURITY INTEREST Recorded Aug 1, 2022
From: SHIELD TX (UK) LIMITED
To: AOP HEALTH INTERNATIONAL MANAGEMENT AG
Reel/Frame 060684/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2019
From: IRON THERAPEUTICS AG
To: SHIELD TX (UK) LTD.
Reel/Frame 050419/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2013
From: STOCKHAM, MICHAEL ARTHUR
To: IRON THERAPEUTICS HOLDINGS AG
Reel/Frame 031778/0847 →
Priority Claims (1)
GB 1101370.3 · Jan 27, 2011 · national
Continuity (1)
Related Publication 20140088064A1 · Mar 27, 2014